Home
About Biowin
Contact us

BioWin

468 X 60

Biopharmacy
Cell therapy
Radiopharmacy
Biotech products
Diagnostics
Medical devices
Imaging
Support
- Investment
- Partnering

Archive for 'December,2012'

Euroscreen UPDATE: Euroscreen completes €10 million financing round!

Euroscreen UPDATE: Euroscreen completes €10 million financing round!

Euroscreen has recently announced the completion of a €10 million Series A preferred stock financing led by Vesalius Biocapital II Partners and SRIW(Société Régionale d’Investissement de Wallonie SA). The proceeds of the round will mainly be used to fund and develop the [...]

Launch of OncoDNA(Gosselies, Belgium) to focus entirely on personalized DNA sequencing of cancer patients.

Launch of OncoDNA(Gosselies, Belgium) to focus entirely on personalized DNA sequencing of cancer patients.

The company will focus entirely on personalized DNA sequencing* of cancer patients. Detiffe, a former CEO and founder of DNAVision, recently announced the launch of OncoDNA(Gosselies, Belgium) after receiving funding of more than €2 million ($2.6 [...]

DNAlytics welcomes new customers after receiving official “UCL spin-off” label and support from the Caring Entrepreneurship Fund.

DNAlytics welcomes new customers after receiving official “UCL spin-off” label and support from the Caring Entrepreneurship Fund.

Founded in April 2012 by Prof. Pierre Dupont and Dr. Thibault Helleputte, privately held company DNAlytics(Louvain-la-Neuve, Belgium) has recently become a new spin-off of the Université Catholique de Louvain (UCL). During the summer of 2012 a [...]

BioWin Day 2016

Popular
Recent
Comments
Tags

UCL makes new discovery with intestinal bacterium that may fight obesity and diabetes

UCL makes new discovery with intestinal bacterium that may fight obesity and diabetes

June 21, 2013

Marie Curie research grant awards €3.8 million in funding to Bone Therapeutics (Gosselies, Belgium) and partners

Marie Curie research grant awards €3.8 million in funding to Bone Therapeutics (Gosselies, Belgium) and partners

January 16, 2014

Opening Bell Ceremony kicks off Advanced Therapies Investor Day (Brussels)

Opening Bell Ceremony kicks off Advanced Therapies Investor Day (Brussels)

January 17, 2014

Bioxodes to develop antithrombotic peptide derived from tick saliva following €2.6 million seed funding round

Bioxodes to develop antithrombotic peptide derived from tick saliva following €2.6 million seed funding round

January 22, 2014

ZenTech Biotechnology, an example of international development!

ZenTech Biotechnology, an example of international development!

February 06, 2014

Imaging beta-cells for better diabetes treatment

Imaging beta-cells for better diabetes treatment

March 22, 2018

Walloon radioisotope in the fight against cancer

Walloon radioisotope in the fight against cancer

October 23, 2017

Personalised arthritis medicine saves lots of money

Personalised arthritis medicine saves lots of money

April 06, 2017

Adrenaline junkie? Raising capital could be for you!

Adrenaline junkie? Raising capital could be for you!

January 19, 2017

BioWin supports the ‘SMART’ project

BioWin supports the ‘SMART’ project

December 22, 2016

Arthritis Awards Biomarkers biomaterial Biotechnology BioWin Cancer Cancer Therapy cancer treatment cardiology Cell therapy Clinical Studies Clinical Trials CNS Data & Statistics Diabetes Disease DNA Genetics Gosselies heart failure Imaging Immunology in-vitro inflammation Investments & Funding joint disorders Laboratory Nuclear Medicine Obesity oncology osteoarthritis Osteonecrosis Partnering spin-off stem cell UCB UCL UCL spin-off ULB ULg UMons Updates vaccines Wallonia

Recent Posts

Imaging beta-cells for better diabetes treatment
Walloon radioisotope in the fight against cancer
Personalised arthritis medicine saves lots of money
Adrenaline junkie? Raising capital could be for you!
BioWin supports the ‘SMART’ project

Archives

Archives

© 2019 Win Health | The health blog of Wallonia. All Rights Reserved.

Powered by Biowin